Welcome to our dedicated page for Eventide International ETF news (Ticker: ESIM), a resource for investors and traders seeking the latest updates and insights on Eventide International ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Eventide International ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Eventide International ETF's position in the market.
Eventide Asset Management (NYSE Arca: ESIM) announced filing approval for the Eventide International ETF (ESIM), its first dedicated ex-US ETF. The fund is expected to begin trading in December 2025 after the November 12, 2025 filing approval. ESIM uses Eventide's Business 360® screening to build an investable universe and applies quantitative risk modeling to align the fund with benchmark factors.
ESIM tracks the Bloomberg World ex US Large & Mid Cap Total Return Index as its benchmark, is not an index fund, and will be managed by Chris Grogan, CFA, and Tyler Frugia.
FAQ
What is the current stock price of Eventide International ETF (ESIM)?
